Literature DB >> 15583368

Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study.

Boukje A C van Dijk1, Leo J Schouten, Lambertus A L M Kiemeney, R Alexandra Goldbohm, Piet A van den Brandt.   

Abstract

Data from the Netherlands Cohort Study on Diet and Cancer were used to investigate the association between anthropometry, energy intake, and physical activity and risk of renal cell carcinoma (RCC). The Netherlands Cohort Study on Diet and Cancer consists of 120,852 men and women aged 55-69 years who completed a self-administered questionnaire at baseline (1986). A case-cohort approach was used. After 9.3 years of follow-up, 275 microscopically confirmed incident cases were available for analysis. Incidence rate ratios for RCC were estimated using Cox proportional hazards models. Height was associated with RCC risk only in women (per 5-cm increment, rate ratio (RR) = 1.23, 95% confidence interval (CI): 1.03, 1.46). Body mass index (weight (kg)/height (m)(2)) was associated with increased risk of RCC (per 1-kg/m(2 )increment, RR = 1.07, 95% CI: 1.02, 1.12) for men and women, as was gain in body mass index from age 20 years to baseline (per 1-kg/m(2 )increment, RR = 1.06, 95% CI: 1.01, 1.10). Energy intake was not related to RCC risk, while a possible protective effect was observed for physical activity in men. These results suggest that body mass index and gain in body mass index since age 20 are associated with increased risk of RCC.

Entities:  

Mesh:

Year:  2004        PMID: 15583368     DOI: 10.1093/aje/kwh344

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

Review 1.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 2.  Height and kidney cancer risk: a meta-analysis of prospective studies.

Authors:  Sudong Liang; Gaofei Lv; Weikai Chen; Jianxin Jiang; Jingqun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-12       Impact factor: 4.553

3.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

4.  Body mass index and renal cell cancer: the influence of race and sex.

Authors:  Jennifer L Beebe-Dimmer; Joanne S Colt; Julie J Ruterbusch; Gregory R Keele; Mark P Purdue; Sholom Wacholder; Barry I Graubard; Faith Davis; Wong-Ho Chow; Kendra L Schwartz
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

5.  Reduced risk of incident kidney cancer from walking and running.

Authors:  Paul T Williams
Journal:  Med Sci Sports Exerc       Date:  2014-02       Impact factor: 5.411

6.  Body size and renal cell cancer incidence in a large US cohort study.

Authors:  Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow
Journal:  Am J Epidemiol       Date:  2008-06-09       Impact factor: 4.897

7.  Contemporary epidemiology of renal cell cancer.

Authors:  Wong-Ho Chow; Susan S Devesa
Journal:  Cancer J       Date:  2008 Sep-Oct       Impact factor: 3.360

8.  Physical activity during adulthood and adolescence in relation to renal cell cancer.

Authors:  Steven C Moore; Wong-Ho Chow; Arthur Schatzkin; Kenneth F Adams; Yikyung Park; Rachel Ballard-Barbash; Albert Hollenbeck; Michael F Leitzmann
Journal:  Am J Epidemiol       Date:  2008-05-08       Impact factor: 4.897

Review 9.  The epidemiology and risk factors for renal cancer.

Authors:  Tahir Qayyum; Grenville Oades; Paul Horgan; Michael Aitchison; Joanne Edwards
Journal:  Curr Urol       Date:  2013-02-08

Review 10.  The association between physical activity and renal cancer: systematic review and meta-analysis.

Authors:  G Behrens; M F Leitzmann
Journal:  Br J Cancer       Date:  2013-02-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.